Mast cells may also contribute to an immunosuppressive tumour microenvironment as they mobilize the infiltration of myeloid‐derived suppressor cells (MDSCs) into tumours and induce the production of IL‐17 by MDSCs 47, which indirectly attracts Tregs, enhancing their suppressor function and IL‐9 production; in turn, IL‐9 strengthens the survival and pro‐tumour effect of intratumoral mast cells. Here, IL17A is linked to neoplasm.